Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
16 September 2021 | Story Nonsindiso Qwabe | Photo Supplied
Dr Samantha Potgieter.

As COVID-19 vaccines continue to be a topical issue in South Africa and indeed in the world itself, the Department of Human Resources held a webinar for the UFS community on 10 September that delved deeper into the questions surrounding the vaccine. 

Dr Samantha Potgieter, infectious disease expert at the Universitas Academic Hospital and affiliated Lecturer in the Department of Internal Medicine at the University of the Free State, addressed some commonly raised concerns about the COVID-19 vaccine and how it affects us.

Dr Potgieter started off by saying that coronaviruses have been causing outbreaks among humans for millennia. While COVID-19 is relatively mild and self-limiting in 80% of patients, 20% of patients are at risk of developing severe disease.
She said before a vaccine could be introduced to a population, it had to go through rigorous testing and clinical trials. Only once safety has been confirmed, it can be released and distributed. 

“This process usually takes about ten years; this is what we are used to. But it has happened much quicker for the COVID-19 vaccine, and I think this is a fact that many people misinterpret – that the evidence might not be that robust, which is certainly not the case. COVID-19 vaccines have gone through all this rigorous testing, thousands of patients had volunteered for trial testing studies. The point is that we already had the technology, vaccination is not something new to humans. So, these preclinical trials were able to happen very quickly, and because of the large number of infections and because the focus of the entire world was on finding a cure, it was a very set process to get these trials through the adequate phases.” 

She said the COVID-19 vaccine was approved by national regulators, manufactured to exacting standards, and only thereafter distributed – as is the case for all drugs released into the market.

How does the vaccine work?

Dr Potgieter said the vaccine works by producing antibodies against the COVID-19 virus. If you are infected with the COVID-19 virus after getting vaccinated, these antibodies bind to the virus and stop it from replicating.

“When you get infected with a disease such as COVID-19, natural antibodies are produced by the immune system to fight the disease. If you get infected again, the immune system will remember how to respond, and quickly destroy the virus. A vaccine can do the same, but without the risk of disease from natural infection. Vaccines work by imitating a bacteria or virus using either mRNA in the case of the COVID-19 vaccine, or a dead or weakened version of the bacteria or virus. The vaccine raises the body’s alarm. It trains the body to recognise and fight the virus. When the body encounters the real-deal virus, it is primed and ready to fight for the body’s health.”

She said South Africa had the mRNA vaccine in the form of the Pfizer vaccine, and the adenoviral vector vaccine in the form of the Johnson & Johnson vaccine.

Why should you get the vaccine?

Dr Potgieter said vaccines are safe and effective, and the most compelling reasons for getting vaccinated are the following:

-To protect yourself from severe disease
-To protect those around you who may be at risk of severe disease
-To restore the social and economic platforms of the country, and the world at large.
She said that while the vaccine does not prevent you from getting COVID-19, it offers better protection against the development of severe disease, and vaccinated people had 50% less chance of spreading the virus.
The most common side effects of the vaccine are the following:
-Pain at the injection site
-Swollen lymph nodes
-Fever
-Fatigue
-Headache
-Myalgia (muscle pain)

“These are indications that the immune system is mounting a response. When it mounts a response, it produces antibodies,” she said.

Answers to commonly asked questions are the following:

1. Can the vaccine alter my DNA?
“No, it goes nowhere near the nucleus of the cell.”

2. What happens when you get COVID in between the first and second doses?
“Some protection is conferred after the first dose, but maximum protection is conferred two weeks after the second dose. Vaccination is still advised.” 

Dr Potgieter said patients who were between vaccinations still show better recovery results than those without.

3. What about natural immunity?
“Natural immunity might confer better protection, but it runs the risk of severe disease. Yes, immunity can be gained through natural immunity, it can be gained through vaccination, and it can certainly be gained by a combination of the two.”

4. What about long-term side effects?
“Serious side effects that cause long-term health problems following any vaccination are very rare, including the COVID-19 vaccination.”

To get the answers to more of your questions, the webinar can be accessed via the following link: https://event.webinarjam.com/go/replay/43/053q6a8vay9a0qa2

News Archive

Penny Siopis recipient of the prestigious Helgaard Steyn Award
2015-12-15

Vanya Terblance (ABSA Trust representative) hands over the award to Penny Siopis
Photo: Valentino Ndaba

On Friday 4 December 2015, Penny Siopis, the well-known Cape Town-based artist, who has been exhibiting her work locally and internationally since 1975, was presented with the 2015 Helgaard Steyn Award and a prize of R 550 000 for her painting entitled Swarm.

A quadrennial award lunch was hosted by the University of the Free State (UFS) Johannes Stegman Gallery in conjunction with the Helgaard Steyn and ABSA Trusts. The Helgaard Steyn Trust was established by the estate of Dr Jan Steyn and was named after his father and his brother who was the last president of the Orange Free State Republic.

Swarm, a 2011 painting using ink and glue on canvas, depicts a swarm of bees in a complex, dynamic, and intense manner. It earned the prestigious award that is dedicated to the promotion of artistic culture based on the adjudicators’ unanimous decision. Angela de Jesus, curator of the Johannes Stegmann Art Gallery at the UFS, Annali Dempsey of the University of Johannesburg Gallery, and Prof John Botha, Associate Professor in Art History at North West University, made up the 2015 panel of judges.

On receiving the award, Siopis thanked the Steyn family, the judges, and the people who nominated her. “I am struck by how fantastic it feels to be acknowledged. It is extraordinary when people are struck by what was your own world and the intensity buzzing in your head.”

According to Prof Botha, “Naturally the work of art is chosen on grounds of artistic merit and in the context of contemporary values with regards to both form and content.”

The award-winning painter studied Fine Arts at Rhodes University and Portsmouth University in United Kingdom. Apart from lecturing Fine Arts at the University of the Witwatersrand, she is an honorary professor at University of Cape Town Michaelis School of Fine Art. She has also taught at the Natal Technicon in Durban.

Siopis has received numerous awards for her work, including a British Council Scholarship, a Merit Award at the 2nd Cape Town Triennial, and the Atelier Award for a residency at the Cité Internationale des Arts in Paris, in addition to the Alexander S Onassis fellowship for research in Greece.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept